NOVEL APPROACHES FOR TRANSURETHRAL EN-BLOC RESECTION OF LARGE BLADDER TUMORS
- Authors: Kislyakov D.A1,2, Severgina L.O1, Tsarichenko D.G1, Rapoport L.M1, Korovin I.A1, Sorokin N.I3
-
Affiliations:
- Sechenov First Moscow State Medical University, Ministry of Health of Russia
- Voskresensk district hospital №2
- M.V. Lomonosov State University
- Issue: No 4 (2019)
- Pages: 105-111
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/312247
- DOI: https://doi.org/10.18565/urology.2019.4.105-111
- ID: 312247
Cite item
Abstract
Full Text
About the authors
D. A Kislyakov
Sechenov First Moscow State Medical University, Ministry of Health of Russia; Voskresensk district hospital №2
Email: dakislyakov@gmail.com
Ph.D. student, FGAOU VO I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, Moscow, Russia, urologist at the Voskresensk district hospital №2 Moscow Russia
L. O Severgina
Sechenov First Moscow State Medical University, Ministry of Health of RussiaMD, professor at the Department of Department of Pathology named after A.I. Strukov; pathologist at the CPAO Moscow Russia
D. G Tsarichenko
Sechenov First Moscow State Medical University, Ministry of Health of RussiaMD, professor Moscow Russia
L. M Rapoport
Sechenov First Moscow State Medical University, Ministry of Health of RussiaMD, professor Moscow Russia
I. A Korovin
Sechenov First Moscow State Medical University, Ministry of Health of Russia5-year student Moscow Russia
N. I Sorokin
M.V. Lomonosov State University
Email: nisorokin@mail.ru
MD, professor Moscow Russia
References
- Gontero P., Sylvester R., Pisano F. et al. The impact of re-TUR on clinical outcomes in a large multi-centre cohort of T1-HG/G3 patients treated with BCG. BJU Int. 2016;118:44-52. doi: 10.1111/bju.13354.
- Francesco Soria, Giancarlo Marra, David D’Andrea, Paolo Gontero, Shahrokh F. Shariat. The rational and benefits of the second look transurethral resection of the bladder for T1 high grade bladder cancer. Transl Androl Urol. 2019;8(1):46-53. doi: 10.21037/tau.2018.10.19.
- EAU Guidelines on non-muscle-invasive bladder cancer (Ta, T1, CIS), 2019.
- Herr H.W., Donat S.M. Quality control in transurethral resection of bladder tumours. BJU Int2008;102:1242-6. Doi: 10.1111/j. 1464-410X.2008.07966.x
- Mariappan P., Finney S.M., Head E. et al. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across. BJU Int. 2012;109:1666-73. doi: 10.1111/j.1464-410X.2011.10571.x
- Maruniak N.A., Takezawa K., Murphy W.M. Accurate pathological staging of urothelial neoplasms requires better cystoscopic sampling. J Urol. 2002;167:2404-2407. doi: 10.1016/S0022-5347(05)64993-2.
- Rouprêt M., Yates D.R., Varinot J. et al. The presence of detrusor muscle in the pathological specimen after transurethral resection of primary pT1 bladder tumors and its relationship to operator experience. Can J Urol. 2012;19:6459-6464.
- Kramer M.W., Rassweiler J.J., Klein J. et al. En bloc resection ofurothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol. 2015;33:1937-1943. doi: 10.1007/s00345-015-1568-6
- Bum Sik Tae, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim, Kyung Chul Moon, Ja Hyeon Ku. Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer. PLoS One. 2017;12(12):e0189354. Doi: 10.1371/ journal.pone.0189354.
- Kawada T., Ebihara K., Suzuki T., Imai K., Yamanaka H. A new technique for transurethral resection of bladder tumors: rotational tumor resection using a new arched electrode. J Urol. 1997;157(6):2225-2226.
- WHO Classification of tumors of the urinary system and male genital organs. Edited by Holger Moch, Peter A. Humphrey, Thomas M. Ulbright, Victor E. Reuter. International agency for research on cancer. Lyon, 2016. 356.